P2RX1 and neoplasm: We simultaneously added external ATP-assisted Dex and Imatinib and combination therapy to the control group and found that apoptosis was increased (Fig. 7h), which further verified the relationship between the activation of the P2RX1 channel and the prognosis of the tumor.